SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-082167
Filing Date
2023-11-01
Accepted
2023-11-01 16:05:29
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_inmunebio.htm   iXBRL 10-Q 777962
2 CERTIFICATION f10q0923ex31-1_inmunebio.htm EX-31.1 9448
3 CERTIFICATION f10q0923ex31-2_inmunebio.htm EX-31.2 9707
4 CERTIFICATION f10q0923ex32-1_inmunebio.htm EX-32.1 4103
5 CERTIFICATION f10q0923ex32-2_inmunebio.htm EX-32.2 3998
  Complete submission text file 0001213900-23-082167.txt   4204842

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20230930.xsd EX-101.SCH 50493
7 XBRL CALCULATION FILE inmb-20230930_cal.xml EX-101.CAL 33065
8 XBRL DEFINITION FILE inmb-20230930_def.xml EX-101.DEF 199159
9 XBRL LABEL FILE inmb-20230930_lab.xml EX-101.LAB 423250
10 XBRL PRESENTATION FILE inmb-20230930_pre.xml EX-101.PRE 211137
55 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_inmunebio_htm.xml XML 462691
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 231368189
SIC: 2836 Biological Products, (No Diagnostic Substances)